Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Seri Park

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Therapeutic Advances in Medical Oncology|August 7, 2023
Pretreatment endocrine symptoms and recurrence-free survival among young premenopausal patients with breast cancer: a prospective cohort studyDanbee Kang, Juhee Cho, Seri Park, et al.
Breast Cancer Research and Treatment|September 6, 2021
Prevalence, treatment patterns, and prognosis of low estrogen receptor-positive (1% to 10%) breast cancer: a single institution's experience in KoreaYeon Hee Park, Vassiliki Karantza, Shawna R Calhoun, et al.
Neurobiology of Learning and Memory|March 21, 2015
Cranial irradiation regulates CREB-BDNF signaling and variant BDNF transcript levels in the mouse hippocampusYeonghoon Son, Miyoung Yang, Sohi Kang, et al.
Frontiers in Oncology|March 22, 2021
The Role of Chemotherapy in Patients With HER2-Negative Isolated Locoregional Recurrence of Breast Cancer: A Multicenter Retrospective Cohort StudyKyoungmin Lee, Sung Hoon Sim, Eun Joo Kang, et al.
Breast Cancer (Tokyo, Japan)|March 13, 2024
Comprehensive Young Age Breast Cancer registry from clinical, genomics, and patient-reported outcomes measured with 15 years follow-up: the CHARM cohort profileDanbee Kang, Seri Park, Hyo Jung Kim, et al.
Molecular Cancer Research : MCR|June 20, 2020
Clinical Characteristics and Exploratory Genomic Analyses of Germline BRCA1 or BRCA2 Mutations in Breast CancerSehhoon Park, Eunjin Lee, Seri Park, et al.
Cancers|October 14, 2022
Long-Term Breast Cancer Outcomes of Pregnancy-Associated Breast Cancer (PABC) in a Prospective CohortHyunji Jo, Seri Park, Hye Ryeon Kim, et al.
Cancer Communications (London, England)|May 30, 2019
Quality of life outcomes including neuropathy-associated scale from a phase II, multicenter, randomized trial of eribulin plus gemcitabine versus paclitaxel plus gemcitabine as first-line chemotherapy for HER2-negative metastatic breast cancer: Korean Cancer Study Group Trial (KCSG BR13-11)Ji-Yeon Kim, Seri Park, Seock-Ah Im, et al.
BMC Medicine|March 17, 2022
HER2 expression, copy number variation and survival outcomes in HER2-low non-metastatic breast cancer: an international multicentre cohort study and TCGA-METABRIC analysisRyan Shea Ying Cong Tan, Whee Sze Ong, Kyung-Hun Lee, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|May 14, 2024
Outcomes in Nonmetastatic Hormone Receptor-Positive HER2-Negative Pure Mucinous Breast Cancer: A Multicenter Cohort StudyRyan Ying Cong Tan, Whee Sze Ong, Kyung-Hun Lee, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Therapeutic Advances in Medical Oncology|August 7, 2023
Pretreatment endocrine symptoms and recurrence-free survival among young premenopausal patients with breast cancer: a prospective cohort studyDanbee Kang, Juhee Cho, Seri Park, et al.
Breast Cancer Research and Treatment|September 6, 2021
Prevalence, treatment patterns, and prognosis of low estrogen receptor-positive (1% to 10%) breast cancer: a single institution's experience in KoreaYeon Hee Park, Vassiliki Karantza, Shawna R Calhoun, et al.
Neurobiology of Learning and Memory|March 21, 2015
Cranial irradiation regulates CREB-BDNF signaling and variant BDNF transcript levels in the mouse hippocampusYeonghoon Son, Miyoung Yang, Sohi Kang, et al.
Frontiers in Oncology|March 22, 2021
The Role of Chemotherapy in Patients With HER2-Negative Isolated Locoregional Recurrence of Breast Cancer: A Multicenter Retrospective Cohort StudyKyoungmin Lee, Sung Hoon Sim, Eun Joo Kang, et al.
Breast Cancer (Tokyo, Japan)|March 13, 2024
Comprehensive Young Age Breast Cancer registry from clinical, genomics, and patient-reported outcomes measured with 15 years follow-up: the CHARM cohort profileDanbee Kang, Seri Park, Hyo Jung Kim, et al.
Molecular Cancer Research : MCR|June 20, 2020
Clinical Characteristics and Exploratory Genomic Analyses of Germline BRCA1 or BRCA2 Mutations in Breast CancerSehhoon Park, Eunjin Lee, Seri Park, et al.
Cancers|October 14, 2022
Long-Term Breast Cancer Outcomes of Pregnancy-Associated Breast Cancer (PABC) in a Prospective CohortHyunji Jo, Seri Park, Hye Ryeon Kim, et al.
Cancer Communications (London, England)|May 30, 2019
Quality of life outcomes including neuropathy-associated scale from a phase II, multicenter, randomized trial of eribulin plus gemcitabine versus paclitaxel plus gemcitabine as first-line chemotherapy for HER2-negative metastatic breast cancer: Korean Cancer Study Group Trial (KCSG BR13-11)Ji-Yeon Kim, Seri Park, Seock-Ah Im, et al.
BMC Medicine|March 17, 2022
HER2 expression, copy number variation and survival outcomes in HER2-low non-metastatic breast cancer: an international multicentre cohort study and TCGA-METABRIC analysisRyan Shea Ying Cong Tan, Whee Sze Ong, Kyung-Hun Lee, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|May 14, 2024
Outcomes in Nonmetastatic Hormone Receptor-Positive HER2-Negative Pure Mucinous Breast Cancer: A Multicenter Cohort StudyRyan Ying Cong Tan, Whee Sze Ong, Kyung-Hun Lee, et al.
Pageof 3